GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Study by Özcan and Kaya Finds Motor Support Programs Improve Developmental Outcomes in Children with Autism Spectrum Disorder

by GOAI
Share To

A recent study conducted by researchers Özcan and Kaya has examined the effects of motor support programs on the development of children diagnosed with Autism Spectrum Disorder (ASD). The findings highlight the potential influence of such programs on various aspects of growth, including physical, cognitive, and social development. The research focuses on understanding how targeted motor interventions can contribute to improving the overall well-being and developmental progress of autistic children.

The study explores the role of structured motor support in addressing challenges commonly faced by children with ASD. Researchers analyzed data from participants engaged in these programs, assessing changes across multiple developmental domains. The results indicate that incorporating motor-based activities may positively impact not only physical coordination but also cognitive functions and social interaction skills. This research adds to a growing body of evidence aimed at identifying effective strategies for supporting individuals with autism through tailored interventions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top